[go: up one dir, main page]

PL1808170T3 - Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową - Google Patents

Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową

Info

Publication number
PL1808170T3
PL1808170T3 PL05805529T PL05805529T PL1808170T3 PL 1808170 T3 PL1808170 T3 PL 1808170T3 PL 05805529 T PL05805529 T PL 05805529T PL 05805529 T PL05805529 T PL 05805529T PL 1808170 T3 PL1808170 T3 PL 1808170T3
Authority
PL
Poland
Prior art keywords
aqueous eye
accelerated
eye drop
eye drops
aqueous
Prior art date
Application number
PL05805529T
Other languages
English (en)
Inventor
Shirou Sawa
Tomoko Nakajima
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of PL1808170T3 publication Critical patent/PL1808170T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05805529T 2004-11-05 2005-11-04 Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową PL1808170T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004322569 2004-11-05
EP05805529A EP1808170B1 (en) 2004-11-05 2005-11-04 Aqueous eye drops with accelerated intraocular migration
PCT/JP2005/020302 WO2006049250A1 (ja) 2004-11-05 2005-11-04 眼内移行性促進水性点眼剤

Publications (1)

Publication Number Publication Date
PL1808170T3 true PL1808170T3 (pl) 2011-12-30

Family

ID=36319250

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05805529T PL1808170T3 (pl) 2004-11-05 2005-11-04 Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową

Country Status (11)

Country Link
US (3) US20070021507A1 (pl)
EP (1) EP1808170B1 (pl)
JP (1) JP4933897B2 (pl)
KR (2) KR101312740B1 (pl)
CN (1) CN1993118B (pl)
AT (1) ATE520394T1 (pl)
CA (1) CA2560559C (pl)
ES (1) ES2369089T3 (pl)
MX (1) MX2007001172A (pl)
PL (1) PL1808170T3 (pl)
WO (1) WO2006049250A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI465236B (zh) * 2007-03-13 2014-12-21 參天製藥股份有限公司 含有吡諾克辛之懸浮型水性液劑
CN101313899B (zh) * 2007-06-01 2012-02-29 北京德众万全药物技术开发有限公司 一种含有溴芬酸钠的眼用药物组合物
WO2009117086A2 (en) * 2008-03-17 2009-09-24 Cardiac Pacemakers, Inc. Deactivation of intermittent pacing therapy
JP5219879B2 (ja) * 2009-02-20 2013-06-26 倉敷紡績株式会社 logPの決定方法、および該方法に使用される二相系溶媒
US8778999B2 (en) 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
EP2269575A1 (en) * 2009-06-30 2011-01-05 Santen Pharmaceutical Co., Ltd Method for improving bioavailability of latanoprost
CN102557976B (zh) * 2010-12-15 2015-06-10 辽宁盛京制药有限公司 溴芬酸有机盐及其制备方法、其组合物及用途
WO2012099142A1 (ja) * 2011-01-18 2012-07-26 千寿製薬株式会社 保存効力を有するブロムフェナク水性液剤組成物
JP6012231B2 (ja) * 2011-04-08 2016-10-25 ロート製薬株式会社 ブロムフェナク含有組成物
JP2016522257A (ja) * 2013-06-19 2016-07-28 センティス リサーチ センター 安定なブロムフェナク溶液
CN105451731B (zh) * 2013-09-26 2019-01-18 参天制药株式会社 含有经稳定化的2-氨基-3-(4-溴苯甲酰基)苯乙酸的水性组合物
JP7223712B2 (ja) 2017-02-21 2023-02-16 ティアソリューションズ・インコーポレイテッド 安定なペプチド組成物
CN111743858B (zh) * 2019-03-29 2023-06-27 天津药业研究院股份有限公司 一种溴芬酸钠的药物组合物
CN112823784B (zh) * 2019-11-20 2022-09-16 湖北远大天天明制药有限公司 吡诺克辛钠滴眼液以及用于眼部给药的溶液

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860160A (en) * 1956-11-19 1958-11-11 Gen Aniline & Film Corp Preparation of aminoalkyl acids and derivatives thereof
JPS5989617A (ja) 1982-11-15 1984-05-23 Lion Corp 点眼液
JPS5989616A (ja) 1982-11-15 1984-05-23 Lion Corp 点眼液
JPS6112617A (ja) 1984-06-27 1986-01-21 Lion Corp 点眼液
US4563291A (en) * 1984-07-20 1986-01-07 Halliburton Company Method of preparation of substituted amino-alkyl sulfonic acid compounds and use in the treatment of subterranean formations
DE3612538A1 (de) 1986-04-14 1987-10-15 Dispersa Ag Stabilisierung von quecksilberhaltigen konservierungsmitteln in augentropfen
DE3612537C1 (de) * 1986-04-14 1987-07-16 Dispersa Ag Arzneimittel zur Behandlung von Entzuendungen im Auge
JP2563336B2 (ja) 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
US4910225A (en) * 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
US5639481A (en) * 1994-10-17 1997-06-17 Symbollon Corporation Method for the therapeutic treatment of a mammalian eye using an admixed composition containing free molecular iodine
US5849291A (en) * 1994-10-17 1998-12-15 Symbollon Corporation Opthalmic non-irritating iodine medicament
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
WO1996019211A1 (en) * 1994-12-19 1996-06-27 Taisho Pharmaceutical Co., Ltd. Liposome eye drops
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
JP3170619B2 (ja) * 1995-04-20 2001-05-28 参天製薬株式会社 有機アミンを配合したプラノプロフェン点眼液
US6335335B2 (en) * 1997-11-05 2002-01-01 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
CN1124842C (zh) 1997-11-05 2003-10-22 千寿制药株式会社 缓释滴眼剂
JP4309974B2 (ja) * 1998-05-21 2009-08-05 日油株式会社 眼科用製剤
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
JP4752987B2 (ja) * 2000-10-12 2011-08-17 ライオン株式会社 外用剤組成物
US20040120916A1 (en) * 2002-12-23 2004-06-24 Advanced Medical Optics, Inc. Contact lens care compositions, methods of use and preparation which protect ocular tissue membrane integrity
ATE393627T1 (de) * 2003-01-21 2008-05-15 Senju Pharma Co Wässrige flüssige zubereitung mit 2-amino-3-(4- bromobenzoyl)phenylessigsäure
JP2007501799A (ja) * 2003-08-07 2007-02-01 アラーガン、インコーポレイテッド 眼内に医薬を送達するための組成物ならびにその調製方法および使用方法
ATE552838T1 (de) 2003-11-14 2012-04-15 Senju Pharma Co Wässrige lösung mit aminoglykosid-antibiotikum und bromfenac

Also Published As

Publication number Publication date
US20070021507A1 (en) 2007-01-25
ES2369089T3 (es) 2011-11-25
JP4933897B2 (ja) 2012-05-16
EP1808170B1 (en) 2011-08-17
KR20070073600A (ko) 2007-07-10
CA2560559C (en) 2013-07-02
CN1993118B (zh) 2010-06-16
ATE520394T1 (de) 2011-09-15
WO2006049250A1 (ja) 2006-05-11
KR20130080061A (ko) 2013-07-11
US20130005815A1 (en) 2013-01-03
EP1808170A4 (en) 2008-03-12
US20120095101A1 (en) 2012-04-19
KR101312740B1 (ko) 2013-09-27
US8518996B2 (en) 2013-08-27
JPWO2006049250A1 (ja) 2008-05-29
CN1993118A (zh) 2007-07-04
EP1808170A1 (en) 2007-07-18
CA2560559A1 (en) 2006-05-11
MX2007001172A (es) 2007-03-12
US8299124B2 (en) 2012-10-30

Similar Documents

Publication Publication Date Title
PL1808170T3 (pl) Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową
EA201000441A1 (ru) Водные офтальмологические препараты
BRPI0413075A (pt) sistema de lente intra-ocular primária e suplementar
NO20083710L (no) Dihydrotienopyrimidin for behandling av betennelsesforstyrrelser
ATE275552T1 (de) 1-substituierte-1-aminomethyl-cycloalkan derivate (= gabapentin analoga), deren herstellung und deren verwendung bei der behandlung von neurologischen erkrankungen
ATE322895T1 (de) Coenzym q10 zur behandlung von erkrankungen der augen
BR0309185A (pt) Medicamento contendo beta-miméticos e um novo anticolinérgico
GEP20125438B (en) 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
BR0213970A (pt) Amidas de ácido antranìlico e uso farmacêutico dessas amidas
ATE210980T1 (de) Verwendung von indolderivaten zur behandlung von dermatologischen krankheiten, peridhren neuropathien, arthritis, allergischen oder chronisch-obstruktiven atemwegserkrankungen, glaukom und augenentzündungen
KR950032171A (ko) 옥소피리디닐퀴녹살린 유도체
MY136322A (en) Anthranilic acid amides and pharmaceutical use thereof
CN201917722U (zh) 猫类动物用眼镜
ATE444754T1 (de) Verwendung von tyrosinkinase-inhibitoren zur behandlung inflammatorischer prozesse
CY1121044T1 (el) Συνθεσεις και μεθοδοι για τη θεραπεια οφθαλμικων διαταραχων
BRPI0517972A (pt) ácido 5,6,7-triidroxiheptanóico e análogos para o tratamento de doenças oculares e doenças associadas com respostas hiperproliferativas e angiogênicas
PT1289945E (pt) Derivados dissulfureto de anilina para o tratamento de doencas alergicas
WO2008090742A1 (ja) 眼疾患モデル用非ヒト動物
ATE428412T1 (de) Behandlung von augenkrankheiten mit harnstoff und harnstoffderivaten
RU2019118904A (ru) Распределение в глазу и фармакокинетика композиций лифитеграста
CA2468811A1 (en) Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
TW200724138A (en) Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use
MXPA04012685A (es) Derivados de acido benzoico orto-sustituidos para el tratamiento de la resistencia a la insulina.
RU2007101202A (ru) Способ лечения начальной стадии возрастной катаракты
ES2603641T3 (es) Tratamiento de la isquemia ocular y cerebral